ABSTRACT
SAŽETAK

Akutni pankreatitis predstavlja akutno neinfektivno zapaljenje pankreasa, prouzrokovano prevremenom i ektopič-nom aktivacijom pankreasnih digestivnih enzima. Enzimi PRSS1 and SPINK1, koji igraju neke od najvažnijih uloga u pankreasnoj autodigestiji, prvi su otkriveni faktori genetske predispozicije za nastanak pankreatitisa. Ipak, zastupljenost njihovih genetskih varijacija varira u zavisnosti od etničke pripadnosti, što u velikoj meri utiče na značaj njihovog učešća u ovoj bolesti širom sveta. Cilj ove studije bio je da ispita distribuciju najznačajnijih funkcionalnih varijacija gena PRSS1 (86A>T i 365G>A) i SPINK1 (101A>G), kao i njihov uticaj na kliničku sliku bolesti, kod Srba obolelih od akutnog pankreatitisa. Istraživanje je uključilo 81 ispitanika, težina bolesti određivana je uz korišćenje Atlanta klasifi kacionog sistema, a genotipizacija je sprovedena pomoću PCR-RFLP metode. PRSS1 polimorfi zmi 86A>T i 365G>A SNPs nisu detektovani u ispitivanoj populaciji, dok je uče-stalost SPINK1 101A>G varijacije iznosila 0,62% (95% IP: 0,00; 3,83%). Obzirom na ekstremno nisku učestalost ili potpuno odsustvo ispitivanih varijacija, njihov efekat na težinu i tok akutnog pankreatitisa nije mogao biti potvrđen. Rezultati istraživanja ne preporučuju rutinsku genotipizaciju PRSS1 i SPINK1 kod Srba.
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INTRODUCTION
Acute pancreatitis is an acute nonbacterial inflammation of the pancreas caused by a premature and ectopic activation of pancreatic digestive enzymes (1) (2) (3) . In most cases, the disease is mild and self-limiting. However, more than 25% of patients develop a severe form of acute pancreatitis. Of those, more than half die, often during the first week after admission, due to local complications, haemodynamic instability and/or multiple organ failure (2, (4) (5) (6) . As the treatment outcome highly depends on both the type and timing of the management, early differentiation between mild and severe acute pancreatitis has proven to be of the utmost clinical importance (6) . Ultimately, identification of biomarkers for severe disease course upon the very first admission would be extremely beneficial for improving the chance of a good response to therapy.
Genetics, and environmental factors significantly contribute to the onset, severity and outcome of acute pancreatitis (7) (8) (9) . Numerous zymogens and inflammatory mediators that regulate the process are polymorphic, and their genetic variations among pancreatitis patients have often been associated with a more severe clinical course and a worse prognosis (3, (10) (11) (12) . Two of the most important role players in pancreatic autodigestion, cationic trypsinogen (protease serine type 1, PRSS1) and pancreatic secretory trypsin inhibitor (PSTI, serine protease inhibitor Kazal type 1, SPINK1), were implicated in the earliest discoveries of the genetic background of pancreatitis (13, 14) . PRSS1 is the major isoform of trypsinogen, the most important pancreatic zymogen, which is catalysed into trypsin by enterokinase or other trypsin molecules (3, 9) . The PRSS1 coding gene is polymorphic, and the most significant variations include 365G>A and 86A>T single nucleotide polymorphisms (SNPs) that are linked to a malfunction of the normal process of trypsin inactivation by trypsin-like molecules and other inhibitors of its enzymatic activity (7) (8) (9) 15) . In contrast, SPINK1 represents the first line of defence against premature trypsinogen activation as it inhibits trypsin activity within pancreatic acinar cells (3, 7, 9, 16) . SPINK1 is also encoded by a polymorphic gene, and its most important variation 101А>G has been associated with the increased risk of acute pancreatitis, especially in the presence of other significant genetic or environmental factors (7, 9, 16) .
Previous research has established that both PRSS1 and SPINK1 polymorphisms have the potential to modulate the clinical presentation and prognosis of pancreatitis. Moreover, the distribution of these variations differs among populations (17) (18) (19) (20) (21) (22) , and this interethnic variability could significantly affect the magnitude of their proposed role in pancreatitis worldwide. The aim of the present study was to investigate the distribution of the most important functional PRSS1 and SPINK1 variations and their influence on the clinical course of acute pancreatitis Serbian patients.
MATERIALS AND METHODS
Study subjects
The study enrolled 81 Serbian patients with diagnosed acute pancreatitis, who were admitted to the Intensive Care Unit of the Clinical Centre Kragujevac in Serbia, from November 2011 until February 2014. Severity of disease course was determined using the Atlanta Classification system (23) . The study was conducted in accordance with the Declaration of Helsinki and its subsequent revisions, and all patients or their legal representatives gave written informed consent. The approval for conducting the study was obtained from the ethics committee at the Clinical Centre Kragujevac.
Genotyping
Genomic DNA was isolated from EDTA blood samples using the QIAamp DNA Mini Kit (QIAGEN GmbH, Hilden, Germany). DNA concentration was determined by a Qubit™ dsDNA HS Assay Kit on the Qubit® 2.0 Fluorometer (Invitrogen, Carlsbad, CA). All PCR reactions were performed on the Techne Genius PCR Thermal Cycler (Techne, Cambridge, UK). The PCR amplicons and restriction fragments were detected by gel electrophoresis on a 2.4% agarose gel stained with Sybr® safe DNA gel stain (Invitrogen, Carlsbad, CA).
A polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method was used for genotyping PRSS1 variation 365G>A (rs111033565, R122H) and was previously reported by Masamune et al. (24) . Briefly, the PCR reaction was performed in a 16 μl mixture of 0.2 μM dNTP Mix (Thermo Scientific, Waltham, MA), 2.5 mM MgCl2, 0.2 μl of primers 5'-TGACCCACATCCCTCTGCTG -3' and 5'-TCTC-CATTTGTCCTGTCTCT -3' (Invitrogen, Carlsbad, CA), 0.5 U of DreamTaqDNA Polymerase (Thermo Scientific, Waltham, MA), and ~20 ng of DNA in 1X PCR buffer (Qiagen, Hilden, Germany). The conditions included an initial denaturation at 95 °C for 5 min; 30 cycles of denaturation at 95 °C for 1 min, annealing at 64 °C for 1 min, extension at 72 °C for 1 min; and a final extension at 72 °C for 5 min. PCR generated 615 bp long amplicons, which remained uncut by the AflIII (NEB, Hertfordshire, UK) restriction enzyme in the presence of the 365G allele. Variant allele 365A was, on the other hand, digested to 323 bp and 292 bp fragments.
PRSS1 SNP 86A>T (rs111033566, N29I) was detected using PCR-RFLP as described by Mora et al. (25) . In short, PCR was performed in a 16 μl reaction mixture, containing ~20 ng of DNA, 0.2 μM dNTP Mix (Thermo Scientific, Waltham, MA), 1.5 mM MgCl 2 , 0.2 μl of primers 5'-CGC-CACCCCTAACATGCTAT-3' and 5'-CTCTCCCAG-GCAGACTGGCC-3' (Invitrogen, Carlsbad, CA) and 0.5 U of DreamTaqDNA Polymerase (Thermo Scientific, Waltham, MA) in a 1X PCR buffer (Qiagen, Hilden, Germany). The PCR conditions were an initial denaturation at 95 °C for 5 min; 40 cycles of denaturation at 95 for 30 sec, annealing at 64 °C for 30 sec, extension at 72 °C for 30 sec; and final extension at 72 °C for 5 min. The amplification resulted in 266 bp long PCR products, which were then exposed to the restriction enzyme TaaI (Thermo Scientific, Waltham, MA). Digestion of the wild type allele yielded three fragments of 102 bp, 79 bp and 85 bp, while variant 86T allele was cut to 181 bp and 85 bp fragments.
Genotyping for SPINK1 101A>G (rs17107315, N34S) was conducted using the PCR-RFLP method according to Gomez-Lira et al. (16) . Briefly, an 138 bp SPINK1 region was amplified in a total PCR mixture amount of 18 μl, including ~20 ng of DNA, 0. 
Statistical analysis
Genotype data were presented as haplotype and genotype frequencies, and the 95% confidence interval calculations were calculated according to the modified Wald method.
RESULTS
The study population was comprised of 54 men and 27 women aged between 23 and 86 (median age 59 years). Of them, 35 and 46 were classified as mild and severe acute pancreatitis patients, respectively. Among the 81 examined Serbian acute pancreatitis patients, PRSS1 86A>T and 365G>A SNPs were not observed. SPINK1 variant 101G was present in the study population with a frequency of 0.62% (95% CI: 0.00, 3.83%), as only one study subject was a heterozygous carrier. This patient was a 48-years old overweight male (BMI: 29.3 kg/m 2 ), cigarette smoker (20 cigarettes per day) and long-term (10 years) alcohol consumer (3 alcohol drinks per day) with confirmed gallstone disease, who developed a severe form of acute necrotizing pancreatitis with pancreatic pseudocyst. This was his first attack of acute pancreatitis, and no one in his family suffered from this condition before. The patient was treated with analgesics, fluid and nutritional support and antibiotics and antisecretory drugs and was discharged from the hospital fully recovered.
DISCUSSION
In the present study, we investigated the distribution of the important functional PRSS1 and SPINK1 polymorphisms among Serbian patients diagnosed with mild or severe acute pancreatitis. To our best knowledge, this is the first study in Serbs on the genetic background of acute pancreatitis. Due to extremely low frequencies or the absence of examined variations, the proposed effect on severity of disease course could not be observed.
PRSS1 is the most abundant pancreatic precursor of trypsin, which becomes active after cleavage of a short, exposed peptide chain named trypsinogen activation peptide (26) . The gene encoding PRSS1 is located on long arm of chromosome 7 (7q35), spans approximately 3.6 kb and comprises 5 exons (27) . This gene is highly polymorphic, with more than 30 genetic variations reported so far (www. uni-leipzig.de/pancreasmutation). The first described and the best studied are exonic gain-of-function G>A and A>T substitutions at positions 365 and 86, respectively (13, 28) . The former leads to an arginine (R) to histidine (H) replacement at codon 122 of the trypsinogen molecule (13) . Because 122R represents the initial site for trypsin autohydrolysis, R122H renders trypsin resistant to inhibition and available for excessive activation of zymogens within the pancreas (29, 30) . On the other hand, 86A>T results in amino acid substitution of asparagine (N) with isoleucine (I) at codon 29 (28) . This causes an alteration of the secondary structure of the protein, making 122R site inaccessible for trypsin attack, thus providing the same autolysis-preventing effect as R122H (29) (30) (31) . Trypsinogen activation should take place only after leaving the pancreas, as the creation of trypsin inside acinar cells would lead to pancreatic autodigestion and inflammation (1-3, 11) . Previous studies found that pancreatitis develops in approximately 80% of carriers of the 365G>A or 86A>T variation. Thus PRSS1 is considered a causative gene in hereditary pancreatitis (8, 29, 31, 32) . However, in spite of the common underlying mechanism, 365G>A and 86A>T result in a different clinical course of the disease, as patients with the N29I substitution generally have milder disease symptoms with a later age of onset (33, 34) .
Hereditary pancreatitis is characterized by multiple attacks of acute pancreatic inflammation that often progresses to a chronic form (8, 29, 31, 32) , confirming that all types of pancreatitis share a common pathogenetic mechanism (7, 8, 11, 32, 35, 36) . Therefore, it could be expected that PRSS1 variations contribute, at least to a certain extent, to the development and severity of sporadic pancreatitis as well. However, in cases without a strong family history, the roles of PRSS1 365G>A and 86A>T are less understood. In addition, there are discrepancies in observations among different populations, implying interethnic differences in PRSS1 variation frequency (21, 25, 31, (37) (38) (39) (40) (41) (42) (43) (44) (45) . In the present study, genotyping of Serbian acute pancreatitis patients of both mild and severe clinical course revealed no carriers of either 365G>A or 86A>T variations in the PRSS1 gene. This corresponds well to the previous data obtained from Caucasians diagnosed with non-hereditary forms of pancreatitis (8, 17, 22, 24, 25, 32, 37, 39, 40, 43, 46) , arguing against genetic testing of PRSS1 in acute pancreatitis cases in our population (35) . Most likely, environmental or other genetic risk and modifying factors are involved in pathogenesis and affect the severity of this disease in Serbs.
SPINK1 is an acute phase protein, synthesized in the acinar cells of the pancreas together with PRSS1. Being a strong protease inhibitor, its main role is to prevent premature trypsinogen activation and pancreatic autodigestion by creating a covalent bond between its lysine residue at position 41 and the catalytic serine residue of trypsin (12, 31, (47) (48) (49) (50) . The SPINK1 coding gene is localized on chromosome 5 (5q32), and it consists of 4 exons spanning a region of approximately 7.5 kb (51) . There are almost 40 genetic variations of SPINK1 identified so far (www.unileipzig.de/pancreasmutation), with an A to G substitution at position 101 among the first and best described in connection with pancreatitis (14, 47) . This is an exonic missense variation that leads to the replacement of asparagine (N) with serine (S) at codon 34 and was discovered in a pancreatitis family without PRSS1 mutations (47) . It has been suggested that N34S renders SPINK1 incapable of inhibiting trypsinogen by causing the conformational changes within the substrate/inhibitor binding segment of the protein (14, 31) . Because control of trypsin activity largely depends on SPINK1, it has been speculated that 101A>G, as a loss-of-function variation, could be at least be partly responsible for inflammation of the pancreas (47) . However, investigations yielded contradictory results (52) . While some of the studies observed no association between this variation and the disease risk or severity (22, 47, 53, 54) , others reported SPINK1 101A>G as either a cause (14, 24) or a cofactor (16, 17, 31, 32, 37, 39, 55) in pancreatitis development.
In the present study, only one out of 81 Serbian acute pancreatitis patients was found to be a carrier of SPINK1 101A>G. The observed frequency belongs to the lower end of the wide span of previously published data for sporadic idiopathic pancreatitis cases among different populations. These include Brazilian (22) , Chinese (44), Japanese (24, 56) , French (38, 43, 47) , German (14, 57) , Italian (16, 40) , Romanian (58), British (53), Spanish (25) , Danish (41), American (31), Polish (42), or Indian (37), presenting with 0.0%, 0.0%, 0.0-3.1%, 0.0-10.3%, 0.5-23.0%, 2.7-9.4%, 5.0%, 18.0%, 18.8%, 19.5%, 25.0%, 28.6%, and 32.5% of 101A>G carriers, respectively. This overall discrepancy could be a consequence of a different composition of patients involved in the studies, i.e., different forms and aetiologies of pancreatitis cases described (38, 59) . However, regardless of the risk factors and clinical presentations, all types of pancreatitis have the same pathogenesis, showing premature and uninhibited pancreatic zymogens activation (7, 8, 11, 32, 35, 36) . Therefore, it is more probable that the difference in observed frequencies demonstrates an interethnic variability in terms of SPINK1 101A>G distribution (42, 44) , which could explain earlier conflicting findings on its role in pancreatitis initiation and severity. As for the Serbian SPINK1 101A>G carrier presented here, the acute attack of the disease in his case was severe. However, he displayed several known pancreatitis risk factors, including being overweight, alcoholism and gallstone disease (12, 15) . Given the advanced age of the patient and the absence of earlier attacks or a heredity pattern, it could be speculated that this variation acted as a disease-modifying component by lowering the threshold for development of pancreatitis triggered by other causes, possibly increasing the severity of the clinical course of this disease. Nevertheless, our observation of an extremely low frequency of SPINK1 101A>G prevents any definite conclusion regarding its significance in the disease aetiology and course and does not support routine genotyping in sporadic cases of acute pancreatitis in Serbs.
In conclusion, in Serbian patients diagnosed with acute pancreatitis, PRSS1 86A>T and 365G>A variations were not observed, while SPINK1 101A>G was present with a frequency of 0.62%. The proposed effect of examined variations on pancreatitis development and severity could not be confirmed. The results do not support routine genotyping of either PRSS1 or SPINK1 in Serbs.
